Curbs on drug prices may ease
Khomba Singh NEW DELHI THERE may be good news for the pharma industry, which has been facing price caps and fighting high input costs. The government is learnt to be considering liberalising the 10% mandatory cap on price hike for drugs outside price control. Non-scheduled drugs or drugs outside the government's direct price control account for about 75% of the Rs 33,000-crore drug retail market. According to drug pricing laws, companies cannot increase prices of drugs by over 10% within 12 months.